Skip to main content
Premium Trial:

Request an Annual Quote

GenoLogics, Illumina Ink Deal for Geneus LIMS

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenoLogics today announced that it and Illumina have signed a worldwide co-selling agreement for the Geneus LIMS software.

Under the agreement, Illumina will market a version of the software pre-configured for its next-generation sequencers and TruSeq sample preparation kits. The pre-configured version will allow researchers to accelerate implementations, track library preparation and instrument runs, and prepare basic reports in weeks instead of months.

GenoLogics' Geneus LIMS software is specifically designed for genomics and next-gen sequencing, allowing researchers to automate workflows and trace samples and projects across multiple instruments and applications within one centralized system, the Victoria, British Columbia-based company said.

Financial and other terms of the deal were not disclosed.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.